What Is Berberine?
Berberine is an isoquinoline alkaloid found naturally in several plants including Berberis vulgaris (barberry), Berberis aristata (tree turmeric), Coptis chinensis (goldenseal), and Phellodendron amurense. It has been used in traditional Chinese and Ayurvedic medicine for thousands of years, primarily for its antimicrobial and gastrointestinal effects. Modern research has repositioned berberine as one of the most pharmacologically compelling plant-derived compounds available, particularly for metabolic health — with clinical data suggesting effects comparable to the pharmaceutical drug Metformin for blood glucose management.
Berberine's rise in the longevity and biohacking community stems from its multi-pathway activity: it activates AMPK (AMP-activated protein kinase), modulates the gut microbiome, improves insulin sensitivity, reduces LDL cholesterol, and activates several longevity-associated signaling pathways. Its oral bioavailability is limited (approximately 5%) due to extensive first-pass metabolism, which has led to the development of dihydroberberine (DHB) — a reduced, more bioavailable form that converts back to berberine in the intestinal wall and achieves roughly 5x higher plasma concentrations at equivalent doses.
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- Efficacy of berberine in patients with type 2 diabetes mellitus
Yin, J., Xing, H., & Ye, J., 2008, Metabolism - Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
Kong, W., Wei, J., Abidi, P., et al., 2004, Nature Medicine - Berberine improves glucose metabolism through induction of glycolysis
Wu, X., Li, Q., Xin, H., Yu, A., & Zhong, M., 2008, American Journal of Physiology-Endocrinology and Metabolism - Structural modulation of gut microbiota by berberine and metformin in patients with type 2 diabetes mellitus
Zhang, X., Zhao, Y., Zhang, M., et al., 2018, Nature Communications - Berberine in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
Lan, J., Zhao, Y., Dong, F., et al., 2015, PLOS ONE